Syndax Pharmaceuticals Ownership 2024 | Who Owns Syndax Pharmaceuticals Now?
Institutional Ownership
102.45%
Insider Ownership
0.82%
Retail Ownership
-3.26%
Institutional Holders
199.00
Syndax Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 9.28% | 0.00% | 7,906,765 | 354,334 | 4.69% | 162,325,885 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.61% | 0.03% | 7,339,004 | -97,612 | -1.31% | 150,669,751 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 6.71% | 9.06% | 5,722,057 | 62,057 | 1.10% | 117,473,830 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.63% | 0.00% | 4,797,089 | -129,895 | -2.64% | 98,484,237 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.56% | 1.06% | 3,888,437 | -333,785 | -7.91% | 79,829,612 | Jun 30, 2024 |
| STATE STREET CORP | 4.25% | 0.00% | 3,622,335 | -1,197,259 | -24.84% | 74,366,538,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.24% | 5.08% | 3,613,631 | 480,518 | 15.34% | 74,187,844 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 3.91% | 2.91% | 3,335,000 | 922,500 | 38.24% | 68,467,550 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.27% | 0.15% | 2,782,853 | 716,168 | 34.65% | 57,131,969 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.53% | 2.30% | 2,153,669 | 545,129 | 33.89% | 44,214,825 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.26% | 0.79% | 1,925,300 | 176,300 | 10.08% | 39,526,409 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.24% | 0.00% | 1,910,623 | 132,075 | 7.43% | 39,233,197 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.15% | 0.05% | 1,830,427 | -201,632 | -9.92% | 37,578,665 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.83% | 0.01% | 1,555,234 | 59,529 | 3.98% | 31,928,946 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.81% | 0.30% | 1,545,528 | 1,241 | 0.08% | 31,729,690 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.69% | 0.01% | 1,444,012 | 133,939 | 10.22% | 29,645,566 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.66% | 8.52% | 1,412,176 | 311,188 | 28.26% | 28,991,973 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.25% | 0.01% | 1,065,508 | 383,634 | 56.26% | 21,874,879 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 1.20% | 9.11% | 1,025,000 | - | - | 21,043,250 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.14% | 0.12% | 970,106 | -74,926 | -7.17% | 19,915,347 | Jun 30, 2024 |
Syndax Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 9.28% of the company's total share outstanding, currently valued at $162.33M. The top 10 institutional shareholders own together 53.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, LLC | 1.03% | 12.07% | 875,000 | - | - | 17,963,750 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 1.20% | 9.11% | 1,025,000 | - | - | 21,043,250 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 6.71% | 9.06% | 5,722,057 | 62,057 | 1.10% | 117,473,830 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.66% | 8.52% | 1,412,176 | 311,188 | 28.26% | 28,991,973 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.24% | 5.08% | 3,613,631 | 480,518 | 15.34% | 74,187,844 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.65% | 3.38% | 551,544 | 551,544 | 100.00% | 11,323,198 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 0.49% | 3.26% | 419,654 | 21,657 | 5.44% | 8,615,497 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.77% | 3.22% | 657,074 | -2,500 | -0.38% | 13,489,729 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 3.91% | 2.91% | 3,335,000 | 922,500 | 38.24% | 68,467,550 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.08% | 2.43% | 65,000 | - | - | 1,334,450 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.96% | 2.30% | 822,047 | 9,083 | 1.12% | 16,876,625 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.53% | 2.30% | 2,153,669 | 545,129 | 33.89% | 44,214,825 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.41% | 2.25% | 350,000 | 200,000 | 133.33% | 7,185,500 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.75% | 2.14% | 640,389 | 640,389 | 100.00% | 13,147,186 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.05% | 1.97% | 894,993 | - | - | 18,374,206 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.43% | 1.79% | 370,000 | 370,000 | 100.00% | 7,596,100 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.70% | 1.65% | 600,698 | -184,113 | -23.46% | 12,332,330 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.97% | 1.50% | 826,500 | 457,500 | 123.98% | 16,968,045 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 0.97% | 1.16% | 825,000 | 506,149 | 158.74% | 16,937,250 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.10% | 1.11% | 83,259 | - | - | 1,709,307 | Jun 30, 2024 |
The largest Syndax Pharmaceuticals shareholder by % of total assets is FORESITE CAPITAL MANAGEMENT IV, LLC. The company owns 875.00K shares of Syndax Pharmaceuticals (SNDX), representing 12.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | 3.91% | 2.91% | 3,335,000 | 922,500 | 38.24% | 68,467,550 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.27% | 0.15% | 2,782,853 | 716,168 | 34.65% | 57,131,969 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.75% | 2.14% | 640,389 | 640,389 | 100.00% | 13,147,186 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.65% | 3.38% | 551,544 | 551,544 | 100.00% | 11,323,198 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.53% | 2.30% | 2,153,669 | 545,129 | 33.89% | 44,214,825 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 0.97% | 1.16% | 825,000 | 506,149 | 158.74% | 16,937,250 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.24% | 5.08% | 3,613,631 | 480,518 | 15.34% | 74,187,844 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.97% | 1.50% | 826,500 | 457,500 | 123.98% | 16,968,045 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.25% | 0.01% | 1,065,508 | 383,634 | 56.26% | 21,874,879 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.43% | 1.79% | 370,000 | 370,000 | 100.00% | 7,596,100 | Jun 30, 2024 |
| BLACKROCK INC. | 9.28% | 0.00% | 7,906,765 | 354,334 | 4.69% | 162,325,885 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.73% | 0.09% | 625,723 | 339,393 | 118.53% | 12,846,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.66% | 8.52% | 1,412,176 | 311,188 | 28.26% | 28,991,973 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.09% | 0.04% | 930,947 | 212,395 | 29.56% | 19,112,342 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.35% | 0.01% | 297,303 | 203,414 | 216.65% | 6,103,630 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.41% | 2.25% | 350,000 | 200,000 | 133.33% | 7,185,500 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.70% | 0.49% | 594,386 | 197,508 | 49.77% | 12,202,745 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.26% | 0.79% | 1,925,300 | 176,300 | 10.08% | 39,526,409 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.65% | 0.00% | 556,414 | 163,728 | 41.69% | 11,423,179 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.50% | 0.02% | 428,949 | 151,021 | 54.34% | 8,806,323 | Jun 30, 2024 |
As of Jun 30 2024, Syndax Pharmaceuticals's largest institutional buyer is AVIDITY PARTNERS MANAGEMENT LP. The company purchased 922.50K stocks of SNDX, valued at $68.47M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 0.33% | 0.00% | 283,827 | -2,175,408 | -88.46% | 5,827,000 | Jun 30, 2024 |
| BVF INC/IL | - | - | - | -1,875,000 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 4.25% | 0.00% | 3,622,335 | -1,197,259 | -24.84% | 74,366,538,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.89% | 0.00% | 756,232 | -1,059,526 | -58.35% | 15,525,442 | Jun 30, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -973,057 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.00% | 0.00% | 852,206 | -802,846 | -48.51% | 17,495,788 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.27% | 0.01% | 228,625 | -551,375 | -70.69% | 4,693,671 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.31% | 0.03% | 260,876 | -524,768 | -66.79% | 5,355,782 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.56% | 1.06% | 3,888,437 | -333,785 | -7.91% | 79,829,612 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.45% | 0.39% | 387,357 | -271,337 | -41.19% | 7,952,439 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.17% | 0.02% | 144,566 | -202,296 | -58.32% | 2,967,940 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.15% | 0.05% | 1,830,427 | -201,632 | -9.92% | 37,578,665 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.21% | 0.01% | 177,920 | -195,318 | -52.33% | 3,652,698 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.70% | 1.65% | 600,698 | -184,113 | -23.46% | 12,332,330 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.10% | 0.01% | 82,849 | -154,157 | -65.04% | 1,700,890 | Jun 30, 2024 |
| UBS GROUP AG | 0.15% | 0.00% | 125,152 | -144,659 | -53.61% | 2,569,371 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.63% | 0.00% | 4,797,089 | -129,895 | -2.64% | 98,484,237 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -109,827 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.61% | 0.03% | 7,339,004 | -97,612 | -1.31% | 150,669,751 | Jun 30, 2024 |
As of Jun 30 2024, Syndax Pharmaceuticals's biggest institutional seller is T. ROWE PRICE INVESTMENT MANAGEMENT, INC.. The company sold -2.18M shares of SNDX, valued at $5.83M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIRST TURN MANAGEMENT, LLC | 0.75% | 2.14% | 640,389 | 640,389 | 100.00% | 13,147,186 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.65% | 3.38% | 551,544 | 551,544 | 100.00% | 11,323,198 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.43% | 1.79% | 370,000 | 370,000 | 100.00% | 7,596,100 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.07% | 0.00% | 62,500 | 62,500 | 100.00% | 1,283,125 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.07% | 0.13% | 62,366 | 62,366 | 100.00% | 1,280,374 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.07% | 0.22% | 55,835 | 55,835 | 100.00% | 1,146,293 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.06% | 0.19% | 48,263 | 48,263 | 100.00% | 990,839 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 47,373 | 47,373 | 100.00% | 971,161 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 44,207 | 44,207 | 100.00% | 907,570 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.05% | 0.02% | 42,195 | 42,195 | 100.00% | 866,263 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.04% | 0.02% | 37,500 | 37,500 | 100.00% | 769,875 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.04% | 0.06% | 33,123 | 33,123 | 100.00% | 680,015 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.03% | 0.00% | 24,500 | 24,500 | 100.00% | 502,985 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.02% | 19,386 | 19,386 | 100.00% | 397,995 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.02% | 0.00% | 13,286 | 13,286 | 100.00% | 272,762 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.05% | 11,404 | 11,404 | 100.00% | 234,115 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.01% | 10,737 | 10,737 | 100.00% | 220,422 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.01% | 0.00% | 9,803 | 9,803 | 100.00% | 201,256 | Jun 30, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 3,395 | 3,395 | 100.00% | 70,000 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.02% | 1,600 | 1,600 | 100.00% | 32,848 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | 0.00% | 750 | 750 | 100.00% | 17,828 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 250 | 250 | 100.00% | 5,133 | Jun 30, 2024 |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 62 | 62 | 100.00% | 1,263 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 48 | 48 | 100.00% | 985 | Jun 30, 2024 |
Syndax Pharmaceuticals's largest new institutional shareholder by number of shares is FIRST TURN MANAGEMENT, LLC, purchased 640.39K shares, valued at $13.15M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -1,875,000 | -100.00% | - | Jun 30, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -973,057 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -109,827 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -77,400 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -55,297 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -38,832 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -30,760 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -23,520 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -21,519 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -17,033 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -16,590 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | - | - | - | -15,523 | -100.00% | - | Jun 30, 2024 |
| PRINCIPLE WEALTH PARTNERS LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | - | - | - | -8,956 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,150 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -218 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
Syndax Pharmaceuticals's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -1.88M shares, valued at -, as of undefined.
Syndax Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.49% | 121,038 | - | - | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.28% | 573,848 | - | - | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.17% | 59,731 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.15% | 180,000 | - | - | Mar 28, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.15% | 656,761 | - | - | Mar 28, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.14% | 494,654 | -600 | -0.12% | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.12% | 13,837 | - | - | Mar 31, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.11% | 185,995 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.10% | 82,339 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 48,187 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.08% | 713,800 | 713,800 | - | Jan 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.08% | 49,652 | 108 | 0.22% | Feb 29, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.08% | 4,249,352 | 1,157,270 | 37.43% | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.08% | 607,500 | -270,600 | -30.82% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 35,378 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 775 | 119 | 18.14% | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.03% | 89,480 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.03% | 42,553 | - | - | Feb 29, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 7,267 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 66,000 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 138,102 | 18,138 | 15.12% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 230,229 | - | - | Mar 31, 2024 |
| Tema ETF Trust | 0.02% | 900 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,555 | 1,508 | 15.01% | Mar 31, 2024 |
| North Square Investments Trust | 0.01% | 137,480 | 15,620 | 12.82% | Feb 29, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 57,456 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,994,760 | -662,027 | -14.22% | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 7,515 | 995 | 15.26% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,544 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 14,362 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 53,870 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 43,894 | 43,894 | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 188,642 | 6,662 | 3.66% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 16,573 | 16,573 | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 51,996 | 2,909 | 5.93% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 25,782 | - | - | Aug 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 749,140 | 116,401 | 18.40% | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 26,111 | - | - | Dec 31, 2023 |
| HARTFORD SERIES FUND INC | 0.00% | 126,431 | -3,259 | -2.51% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,858 | 1,312 | 20.04% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,128 | -404 | -8.91% | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 32,099 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 387,293 | 164,213 | 73.61% | Jan 31, 2024 |
| Destra Investment Trust | 0.00% | 3,660 | 3,660 | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,610 | -161 | -2.79% | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 19,518 | -7,851 | -28.69% | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 124,200 | - | - | Feb 29, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 24,103 | -997 | -3.97% | Mar 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 7,388 | -1,638 | -18.15% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 52,009 | 797 | 1.56% | Mar 31, 2024 |
| ProFunds | 0.00% | 19,561 | -3,578 | -15.46% | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 21,424 | 21,424 | - | Feb 29, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 153,496 | - | - | Jan 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 62,992 | -1,098 | -1.71% | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 94,139 | 3,635 | 4.02% | Feb 29, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 75,337 | 63,536 | 538.40% | Mar 28, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 5,380 | 5,380 | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 21,732 | -250 | -1.14% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 91,662 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 13,338 | -6,004 | -31.04% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 247,101 | 61,359 | 33.03% | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 4,329 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 17,740 | -7,163 | -28.76% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 7,790 | 7,790 | - | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,773 | 546 | 16.92% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,710 | 1,710 | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 3,272 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 23,594 | -2,649 | -10.09% | Mar 31, 2024 |
| Global X Funds | 0.00% | 31,423 | - | - | Jan 31, 2024 |
| SSGA FUNDS | 0.00% | 309 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,505 | -38,944 | -82.08% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 403,331 | 69,877 | 20.96% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 14,587 | 1,179 | 8.79% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 57,715 | 3,500 | 6.46% | Mar 31, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 19,045 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,016 | -435 | -17.75% | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 29,920 | 5,100 | 20.55% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 73,486 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 9,501 | 1,522 | 19.08% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 23,552 | -1,746 | -6.90% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 222 | - | - | Apr 30, 2021 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 35,485 | 1,883 | 5.60% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,410 | - | - | Mar 28, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 5,678 | - | - | Mar 31, 2024 |
| Dunham Funds | 0.00% | 23,817 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 28,229 | 27,200 | 2643.34% | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 7,851 | -437 | -5.27% | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 525 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 74,565 | 11,567 | 18.36% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 87,570 | 5,216 | 6.33% | Feb 29, 2024 |
| Voya PARTNERS INC | 0.00% | 23,800 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 40,194 | 4,120 | 11.42% | Mar 28, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,165,000 | - | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 31,326 | 4,627 | 17.33% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 103,687 | 36,096 | 53.40% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 3,343,742 | 351,783 | 11.76% | Mar 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 184,223 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 22,610 | 12,308 | 119.47% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 197,359 | 14,616 | 8.00% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 871 | - | - | Mar 31, 2024 |
Syndax Pharmaceuticals's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 121.04K shares, compromising 0.49% of its total assets.
Syndax Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 199 | 2.05% |
| 31 Mar, 24 | 195 | 4.28% |
| 31 Dec, 23 | 187 | -5.56% |
| 30 Sep, 23 | 198 | 15.79% |
| 30 Jun, 23 | 171 | 3.64% |
| 31 Mar, 23 | 165 | 2.48% |
| 31 Dec, 22 | 161 | 15.83% |
| 30 Sep, 22 | 139 | 13.93% |
| 30 Jun, 22 | 122 | -11.59% |
| 31 Mar, 22 | 138 | - |
| 31 Dec, 21 | 138 | 8.66% |
| 30 Sep, 21 | 127 | 6.72% |
| 30 Jun, 21 | 119 | -13.77% |
| 31 Mar, 21 | 138 | -8.61% |
| 31 Dec, 20 | 151 | 43.81% |
| 30 Sep, 20 | 105 | -2.78% |
| 30 Jun, 20 | 108 | 25.58% |
| 31 Mar, 20 | 86 | 7.50% |
| 31 Dec, 19 | 80 | 3.90% |
| 30 Sep, 19 | 77 | 4.05% |
| 30 Jun, 19 | 74 | 7.25% |
| 31 Mar, 19 | 69 | -12.66% |
| 31 Dec, 18 | 79 | -2.47% |
| 30 Sep, 18 | 81 | -7.95% |
| 30 Jun, 18 | 88 | 20.55% |
| 31 Mar, 18 | 73 | -5.19% |
| 31 Dec, 17 | 77 | 13.24% |
| 30 Sep, 17 | 68 | 3.03% |
| 30 Jun, 17 | 66 | 4.76% |
| 31 Mar, 17 | 63 | 12.50% |
| 31 Dec, 16 | 56 | 24.44% |
| 30 Sep, 16 | 45 | -6.25% |
| 30 Jun, 16 | 48 | 77.78% |
| 31 Mar, 16 | 27 | - |
As of 30 Jun 24, 199 institutions are holding Syndax Pharmaceuticals's shares, representing an increase of 2.05% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 87,296,920 | -3.26% |
| 31 Mar, 24 | 90,236,973 | 1.79% |
| 31 Dec, 23 | 88,652,891 | 24.90% |
| 30 Sep, 23 | 70,978,190 | 0.52% |
| 30 Jun, 23 | 70,611,555 | -3.17% |
| 31 Mar, 23 | 72,926,241 | 2.29% |
| 31 Dec, 22 | 71,292,288 | 19.17% |
| 30 Sep, 22 | 59,825,792 | 8.33% |
| 30 Jun, 22 | 55,226,072 | 1.22% |
| 31 Mar, 22 | 54,557,907 | 4.06% |
| 31 Dec, 21 | 52,430,991 | 6.83% |
| 30 Sep, 21 | 49,078,360 | -2.24% |
| 30 Jun, 21 | 50,205,177 | 3.54% |
| 31 Mar, 21 | 48,488,810 | 4.28% |
| 31 Dec, 20 | 46,500,650 | 35.83% |
| 30 Sep, 20 | 34,234,707 | 4.86% |
| 30 Jun, 20 | 32,648,417 | 57.23% |
| 31 Mar, 20 | 20,764,660 | 24.50% |
| 31 Dec, 19 | 16,678,888 | -2.70% |
| 30 Sep, 19 | 17,141,923 | -0.19% |
| 30 Jun, 19 | 17,174,122 | 1.21% |
| 31 Mar, 19 | 16,968,523 | 9.68% |
| 31 Dec, 18 | 15,471,031 | 0.86% |
| 30 Sep, 18 | 15,338,612 | 1.68% |
| 30 Jun, 18 | 15,085,618 | -12.15% |
| 31 Mar, 18 | 17,172,892 | 0.00% |
| 31 Dec, 17 | 17,172,349 | 14.21% |
| 30 Sep, 17 | 15,035,256 | -4.27% |
| 30 Jun, 17 | 15,705,729 | 34.78% |
| 31 Mar, 17 | 11,652,921 | 4.76% |
| 31 Dec, 16 | 11,123,509 | -4.10% |
| 30 Sep, 16 | 11,599,076 | 12.92% |
| 30 Jun, 16 | 10,272,347 | 8.77% |
| 31 Mar, 16 | 9,444,050 | - |
Syndax Pharmaceuticals (SNDX) has 87.30M shares outstanding as of 30 Jun 24, down -3.26% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 102.45% | 0.66% |
| 31 Mar, 24 | 124.43% | 0.77% |
| 31 Dec, 23 | 126.91% | 1.22% |
| 30 Sep, 23 | 101.92% | 0.99% |
| 30 Jun, 23 | 101.69% | 0.92% |
| 31 Mar, 23 | 105.02% | 0.76% |
| 31 Dec, 22 | 117.33% | 1.21% |
| 30 Sep, 22 | 98.61% | 1.17% |
| 30 Jun, 22 | 91.80% | 1.07% |
| 31 Mar, 22 | 92.50% | 0.95% |
| 31 Dec, 21 | 98.60% | 1.11% |
| 30 Sep, 21 | 94.45% | 1.00% |
| 30 Jun, 21 | 97.29% | 1.10% |
| 31 Mar, 21 | 94.15% | 0.74% |
| 31 Dec, 20 | 112.57% | 1.87% |
| 30 Sep, 20 | 77.53% | 1.20% |
| 30 Jun, 20 | 80.40% | 2.20% |
| 31 Mar, 20 | 60.49% | 2.02% |
| 31 Dec, 19 | 54.70% | 1.86% |
| 30 Sep, 19 | 54.19% | 1.84% |
| 30 Jun, 19 | 54.34% | 1.38% |
| 31 Mar, 19 | 62.79% | 1.69% |
| 31 Dec, 18 | 60.98% | 1.68% |
| 30 Sep, 18 | 60.22% | 1.62% |
| 30 Jun, 18 | 61.06% | 1.24% |
| 31 Mar, 18 | 70.16% | 1.05% |
| 31 Dec, 17 | 81.78% | 1.79% |
| 30 Sep, 17 | 67.60% | 1.04% |
| 30 Jun, 17 | 80.55% | 1.97% |
| 31 Mar, 17 | 63.92% | 1.10% |
| 31 Dec, 16 | 76.09% | 1.81% |
| 30 Sep, 16 | 64.80% | 1.94% |
| 30 Jun, 16 | 57.81% | 2.05% |
| 31 Mar, 16 | 53.15% | - |
As of 30 Jun 24, Syndax Pharmaceuticals is held by 102.45% institutional shareholders, representing a 0.66% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 109 | -3.54% |
| 31 Mar, 24 | 113 | -4.24% |
| 31 Dec, 23 | 118 | 22.92% |
| 30 Sep, 23 | 96 | -10.28% |
| 30 Jun, 23 | 107 | 8.08% |
| 31 Mar, 23 | 99 | 2.06% |
| 31 Dec, 22 | 97 | 11.49% |
| 30 Sep, 22 | 87 | 42.62% |
| 30 Jun, 22 | 61 | -23.75% |
| 31 Mar, 22 | 80 | 12.68% |
| 31 Dec, 21 | 71 | 24.56% |
| 30 Sep, 21 | 57 | -13.64% |
| 30 Jun, 21 | 66 | -4.35% |
| 31 Mar, 21 | 69 | -35.51% |
| 31 Dec, 20 | 107 | 148.84% |
| 30 Sep, 20 | 43 | -44.16% |
| 30 Jun, 20 | 77 | 45.28% |
| 31 Mar, 20 | 53 | 39.47% |
| 31 Dec, 19 | 38 | 8.57% |
| 30 Sep, 19 | 35 | -22.22% |
| 30 Jun, 19 | 45 | 50.00% |
| 31 Mar, 19 | 30 | -26.83% |
| 31 Dec, 18 | 41 | -2.38% |
| 30 Sep, 18 | 42 | -17.65% |
| 30 Jun, 18 | 51 | 41.67% |
| 31 Mar, 18 | 36 | -23.40% |
| 31 Dec, 17 | 47 | 9.30% |
| 30 Sep, 17 | 43 | - |
| 30 Jun, 17 | 43 | 26.47% |
| 31 Mar, 17 | 34 | 13.33% |
| 31 Dec, 16 | 30 | 36.36% |
| 30 Sep, 16 | 22 | -26.67% |
| 30 Jun, 16 | 30 | 11.11% |
| 31 Mar, 16 | 27 | - |
109 institutional shareholders have increased their position in SNDX stock as of 30 Jun 24 compared to 113 in the previous quarter (a -3.54% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 59 | 9.26% |
| 31 Mar, 24 | 54 | 31.71% |
| 31 Dec, 23 | 41 | -31.67% |
| 30 Sep, 23 | 60 | 57.89% |
| 30 Jun, 23 | 38 | 11.76% |
| 31 Mar, 23 | 34 | -10.53% |
| 31 Dec, 22 | 38 | 40.74% |
| 30 Sep, 22 | 27 | -22.86% |
| 30 Jun, 22 | 35 | 12.90% |
| 31 Mar, 22 | 31 | -11.43% |
| 31 Dec, 21 | 35 | -12.50% |
| 30 Sep, 21 | 40 | 33.33% |
| 30 Jun, 21 | 30 | -33.33% |
| 31 Mar, 21 | 45 | 87.50% |
| 31 Dec, 20 | 24 | -36.84% |
| 30 Sep, 20 | 38 | 171.43% |
| 30 Jun, 20 | 14 | -39.13% |
| 31 Mar, 20 | 23 | 4.55% |
| 31 Dec, 19 | 22 | 46.67% |
| 30 Sep, 19 | 15 | 7.14% |
| 30 Jun, 19 | 14 | -36.36% |
| 31 Mar, 19 | 22 | - |
| 31 Dec, 18 | 22 | 22.22% |
| 30 Sep, 18 | 18 | -5.26% |
| 30 Jun, 18 | 19 | - |
| 31 Mar, 18 | 19 | 11.76% |
| 31 Dec, 17 | 17 | 21.43% |
| 30 Sep, 17 | 14 | 7.69% |
| 30 Jun, 17 | 13 | 18.18% |
| 31 Mar, 17 | 11 | 10.00% |
| 31 Dec, 16 | 10 | -23.08% |
| 30 Sep, 16 | 13 | 30.00% |
| 30 Jun, 16 | 10 | - |
| 31 Mar, 16 | - | - |
59 institutional shareholders have reduced their position in SNDX stock as of 30 Jun 24 compared to 54 in the previous quarter (a 9.26% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 199 | 2.05% | 87,296,920 | -3.26% | 102.45% | 0.66% | 109 | -3.54% | 59 | 9.26% |
| 31 Mar, 24 | 195 | 4.28% | 90,236,973 | 1.79% | 124.43% | 0.77% | 113 | -4.24% | 54 | 31.71% |
| 31 Dec, 23 | 187 | -5.56% | 88,652,891 | 24.90% | 126.91% | 1.22% | 118 | 22.92% | 41 | -31.67% |
| 30 Sep, 23 | 198 | 15.79% | 70,978,190 | 0.52% | 101.92% | 0.99% | 96 | -10.28% | 60 | 57.89% |
| 30 Jun, 23 | 171 | 3.64% | 70,611,555 | -3.17% | 101.69% | 0.92% | 107 | 8.08% | 38 | 11.76% |
| 31 Mar, 23 | 165 | 2.48% | 72,926,241 | 2.29% | 105.02% | 0.76% | 99 | 2.06% | 34 | -10.53% |
| 31 Dec, 22 | 161 | 15.83% | 71,292,288 | 19.17% | 117.33% | 1.21% | 97 | 11.49% | 38 | 40.74% |
| 30 Sep, 22 | 139 | 13.93% | 59,825,792 | 8.33% | 98.61% | 1.17% | 87 | 42.62% | 27 | -22.86% |
| 30 Jun, 22 | 122 | -11.59% | 55,226,072 | 1.22% | 91.80% | 1.07% | 61 | -23.75% | 35 | 12.90% |
| 31 Mar, 22 | 138 | - | 54,557,907 | 4.06% | 92.50% | 0.95% | 80 | 12.68% | 31 | -11.43% |
| 31 Dec, 21 | 138 | 8.66% | 52,430,991 | 6.83% | 98.60% | 1.11% | 71 | 24.56% | 35 | -12.50% |
| 30 Sep, 21 | 127 | 6.72% | 49,078,360 | -2.24% | 94.45% | 1.00% | 57 | -13.64% | 40 | 33.33% |
| 30 Jun, 21 | 119 | -13.77% | 50,205,177 | 3.54% | 97.29% | 1.10% | 66 | -4.35% | 30 | -33.33% |
| 31 Mar, 21 | 138 | -8.61% | 48,488,810 | 4.28% | 94.15% | 0.74% | 69 | -35.51% | 45 | 87.50% |
| 31 Dec, 20 | 151 | 43.81% | 46,500,650 | 35.83% | 112.57% | 1.87% | 107 | 148.84% | 24 | -36.84% |
| 30 Sep, 20 | 105 | -2.78% | 34,234,707 | 4.86% | 77.53% | 1.20% | 43 | -44.16% | 38 | 171.43% |
| 30 Jun, 20 | 108 | 25.58% | 32,648,417 | 57.23% | 80.40% | 2.20% | 77 | 45.28% | 14 | -39.13% |
| 31 Mar, 20 | 86 | 7.50% | 20,764,660 | 24.50% | 60.49% | 2.02% | 53 | 39.47% | 23 | 4.55% |
| 31 Dec, 19 | 80 | 3.90% | 16,678,888 | -2.70% | 54.70% | 1.86% | 38 | 8.57% | 22 | 46.67% |
| 30 Sep, 19 | 77 | 4.05% | 17,141,923 | -0.19% | 54.19% | 1.84% | 35 | -22.22% | 15 | 7.14% |
| 30 Jun, 19 | 74 | 7.25% | 17,174,122 | 1.21% | 54.34% | 1.38% | 45 | 50.00% | 14 | -36.36% |
| 31 Mar, 19 | 69 | -12.66% | 16,968,523 | 9.68% | 62.79% | 1.69% | 30 | -26.83% | 22 | - |
| 31 Dec, 18 | 79 | -2.47% | 15,471,031 | 0.86% | 60.98% | 1.68% | 41 | -2.38% | 22 | 22.22% |
| 30 Sep, 18 | 81 | -7.95% | 15,338,612 | 1.68% | 60.22% | 1.62% | 42 | -17.65% | 18 | -5.26% |
| 30 Jun, 18 | 88 | 20.55% | 15,085,618 | -12.15% | 61.06% | 1.24% | 51 | 41.67% | 19 | - |
| 31 Mar, 18 | 73 | -5.19% | 17,172,892 | 0.00% | 70.16% | 1.05% | 36 | -23.40% | 19 | 11.76% |
| 31 Dec, 17 | 77 | 13.24% | 17,172,349 | 14.21% | 81.78% | 1.79% | 47 | 9.30% | 17 | 21.43% |
| 30 Sep, 17 | 68 | 3.03% | 15,035,256 | -4.27% | 67.60% | 1.04% | 43 | - | 14 | 7.69% |
| 30 Jun, 17 | 66 | 4.76% | 15,705,729 | 34.78% | 80.55% | 1.97% | 43 | 26.47% | 13 | 18.18% |
| 31 Mar, 17 | 63 | 12.50% | 11,652,921 | 4.76% | 63.92% | 1.10% | 34 | 13.33% | 11 | 10.00% |
| 31 Dec, 16 | 56 | 24.44% | 11,123,509 | -4.10% | 76.09% | 1.81% | 30 | 36.36% | 10 | -23.08% |
| 30 Sep, 16 | 45 | -6.25% | 11,599,076 | 12.92% | 64.80% | 1.94% | 22 | -26.67% | 13 | 30.00% |
| 30 Jun, 16 | 48 | 77.78% | 10,272,347 | 8.77% | 57.81% | 2.05% | 30 | 11.11% | 10 | - |
| 31 Mar, 16 | 27 | - | 9,444,050 | - | 53.15% | - | 27 | - | - | - |
Syndax Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of SNDX was made by Goldan Keith A. on Jun 17 2024, buying 1,250 shares at $20.03 per share (worth $25.04K).
Syndax Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | - | - |
| Q1 2024 | 17 | - | - |
| Q3 2023 | 6 | 10 | 60.00% |
| Q2 2023 | 5 | 9 | 55.56% |
| Q1 2023 | 21 | 12 | 175.00% |
| Q4 2022 | 13 | 10 | 130.00% |
| Q3 2022 | 18 | 27 | 66.67% |
| Q2 2022 | 6 | 6 | 100.00% |
| Q1 2022 | 16 | 2 | 800.00% |
| Q4 2021 | 16 | 31 | 51.61% |
| Q3 2021 | 10 | 14 | 71.43% |
| Q2 2021 | 5 | 4 | 125.00% |
| Q1 2021 | 19 | 8 | 237.50% |
| Q4 2020 | 6 | 11 | 54.55% |
| Q3 2020 | 3 | 1 | 300.00% |
| Q1 2020 | 16 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 2 | - | - |
| Q2 2019 | 9 | - | - |
| Q1 2019 | 12 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Syndax Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q3 2023 | - | 5 | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | - | 6 | - |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 12 | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | 2 | - |
| Q4 2021 | - | 11 | - |
| Q3 2021 | - | 9 | - |
| Q2 2021 | 3 | 2 | 150.00% |
| Q1 2021 | - | 4 | - |
| Q4 2020 | - | 7 | - |
| Q3 2020 | - | - | - |
| Q1 2020 | 1 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 2 | - | - |
| Q1 2019 | 3 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Syndax Pharmaceuticals's stocks.
Syndax Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| KALV | KalVista Pharmaceuticals, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| VRDN | Viridian Therapeutics, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| STRO | Sutro Biopharma, Inc. |
| COGT | Cogent Biosciences, Inc. |
| REPL | Replimune Group, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KROS | Keros Therapeutics, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| PCVX | Vaxcyte, Inc. |
| CYTK | Cytokinetics, Incorporated |
| KRTX | Karuna Therapeutics, Inc. |
SNDX Ownership FAQ
Who Owns Syndax Pharmaceuticals?
Syndax Pharmaceuticals is owned by institutional shareholders (102.45%), insiders (0.82%), and public (-3.26%). The largest institutional shareholder of Syndax Pharmaceuticals is BLACKROCK INC. (9.28% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.49% of total shares).
Who are the major institutional shareholders of Syndax Pharmaceuticals?
Syndax Pharmaceuticals's major institutional shareholders are BLACKROCK INC., WELLINGTON MANAGEMENT GROUP LLP, KYNAM CAPITAL MANAGEMENT, LP, VANGUARD GROUP INC, and AVORO CAPITAL ADVISORS LLC. The top five shareholders own together 34.80% of the company's share outstanding.
How many Syndax Pharmaceuticals shareholders are there?
As of Jun 2024, there are 199 institutional shareholders of Syndax Pharmaceuticals.
What percentage of Syndax Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 7.91M shares of Syndax Pharmaceuticals, representing 9.28% of the company's total shares outstanding, valued at $162.33M (as of Jun 2024).
What percentage of Syndax Pharmaceuticals is owned by WELLINGTON MANAGEMENT GROUP LLP?
As of Jun 2024, WELLINGTON MANAGEMENT GROUP LLP holds 7.34M shares of Syndax Pharmaceuticals (SNDX), compromising 8.61% of the company, valued at $150.67M.
What percentage of Syndax Pharmaceuticals is owned by KYNAM CAPITAL MANAGEMENT, LP?
KYNAM CAPITAL MANAGEMENT, LP is the third largest holder of Syndax Pharmaceuticals. The company owns 5.72M of the company's shares outstanding (worth $117.47M).